We confirmed the presence of the APAF1 (c.1669C > T) and TP53 (c.313G > T) mutations in FFPE samples of metastatic tumors by Sanger sequencing (Fig. 2c, right panel). Here, APAF1 is linked to metastatic neoplasm.